Author:
Cahn Anthony,Mehta Rashmi,Preece Andrew,Blowers James,Donald Alison
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference28 articles.
1. Jansat JM, Lamarca R, de Miquel G, Schrödter A, Miletzki B, Gurniak M. Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participants. J Clin Pharmacol. 2009;49:1239–46.
2. Restrepo RD. Use of inhaled anticholinergic agents in obstructive airway disease. Resp Care. 2007;52:833–51.
3. Barnes PJ. The role of anticholinergics in chronic obstructive pulmonary disease. Am J Med. 2004;117:24S–32S.
4. Busch-Petersen J, Lainé DI. Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease. Future Med Chem. 2011;3:1623–34.
5. Fryer AD, Adamko DJ, Yost BL, Jacoby DB. Effects of inflammatory cells on neuronal M2 muscarinic receptor function in the lung. Life Sci. 1999;64:449–55.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献